Skip to main content
. 2020 Jun 19;75(11):2867–2878. doi: 10.1111/all.14408

Table 1.

Patient characteristics of mySinusitisCoach users

Total Controlled Partly controlled Uncontrolled P value*
Number of patients, N (%) 626 146 (23.3%) 184 (29.4%) 296(47.3%)
Age, years (mean ± SD) 43.9 ± 13.4 43.8 ± 14.1 44.2 ± 14.4 43.8 ± 12.5 .95
Male/female 308/318 73/76 88/95 147/147 .92
Chronic rhinosinusitis
sNP 48.2% 44.9% 48.4% 49.6% .68
wNP a 51.8% 55.1% 51.6% 50.4% .68
Pharmaceutical treatment
Nasal corticosteroids 45.2% 39.9% 44.8% 43.5% .54
Oral corticosteroids 4.2% 4.4% 2.7% 4.4% .46
Antibiotics 3.4% 3.8% 3.8% 2.3% .40
Inhaled corticosteroids 15.5% 17.4% 16.9% 13.6% .47
Sinus surgery
Primary 31.9% 34.9% 29.5% 32.0% .58
Revision 20.3% 20.8% 19.1% 20.7% .90
Allergic rhinitis b 48.2% 54.6% 44.8% 47.1% .20
Asthma c
Childhood onset 8.5% 9.8% 8.8% 7.3% .76
Adulthood onset 23.7% 24.1% 21.3% 23.9% .71
COPD d 5.9% 9.0% 6.0% 4.3% .17
Smoking status
Current smoker 11.8% 11.4 9.8% 13.3% .52
Ex‐smoker 18.6% 18.8% 20.8% 17.0% .59
Never smoker 69.6% 69.8% 69.4% 69.7% 1.00
a

Unknown in 82 patients.

b

Unknown in 37 patients.

c

Unknown in 86 patients.

d

Unknown in 67 patients.

*

Comparison between controlled, partly controlled and uncontrolled groups.